MOVE SMART – a feasibility study in patients with psoriasis
Research type
Research Study
Full title
A study to determine the design and feasibility of a randomised controlled clinical trial of MOVE SMART - an intervention to increase physical activity, reduce sedentary behaviour and improve health outcomes in patients with psoriasis.
IRAS ID
335248
Contact name
Helen Young
Contact email
Sponsor organisation
The University of Manchester
ISRCTN Number
ISRCTN17400289
Duration of Study in the UK
1 years, 10 months, 30 days
Research summary
Background and why this study is important
People with psoriasis are less active than others. Psoriasis can lead to heart disease and other conditions. Being more active could prevent this. We created an exercise programme for people with psoriasis. We found, being more active improved psoriasis and reduced the risk of heart disease. Patients found their wellbeing and physical ability improved too. But people were still spending long periods sitting/lying down. As this is also damaging to health, we developed MOVE SMART to help people be more active AND spend less time sitting down.Potential benefits
MOVE SMART is a new lifestyle programme for patients with psoriasis. We want to find out if MOVE SMART helps psoriasis and other conditions linked with psoriasis. To do that, we need to do a clinical trial. This study will find out whether a clinical trial is possible, or not.What's involved
The study will last 24-weeks. All volunteers will continue with their usual treatment and have an equal chance of being in the MOVE SMART group. MOVE SMART will last for 12-weeks. Volunteers will do activities of their own choice during weeks-13-24. MOVE SMART will prompt 2-minutes of activity (only) after 30-minutes sitting/lying down. In Workstream [1] volunteers will wear a small monitor (on their wrist/thigh) to measure activity and sitting time. At Week-1, week-12 and -24 all volunteers will self-assess their psoriasis and wellbeing. The study team will help with this. We will collect blood at these time points using finger-prick kits. Blood pressure and body weight will also be recorded. We will measure physical ability. In Workstream [2] we will find out what people think about MOVE SMART and finalise our proposed clinical trial in Workstream [3].Funding
The study is funded by the NIHR. Recruitment is through expression of interest directly to the research team.REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
24/NW/0362
Date of REC Opinion
19 Dec 2024
REC opinion
Further Information Favourable Opinion